Investing.com - Financial Markets Worldwide

New Ray Medicine International Holding Ltd (6108)

Hong Kong
Currency in HKD
0.440
+0.025(+6.02%)
Closed·
6108 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
6108 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
0.4000.450
52 wk Range
0.3200.840
Key Statistics
Edit
Bid/Ask
0.405 / 0.44
Prev. Close
0.415
Open
0.405
Day's Range
0.4-0.45
52 wk Range
0.32-0.84
Volume
134.24K
Average Volume (3m)
359.75K
1-Year Change
4.76%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
6108 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 14
Trading at a low Price / Book multiple
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

New Ray Medicine International Holding Ltd Company Profile

New Ray Medicine International Holding Limited, an investment holding company, engages in distribution and trading of pharmaceutical and related products in the People’s Republic of China. The company’s pharmaceutical products include levocarnitine injection for the treatment of muscular dystrophy, cardiomyopathy, acute and chronic myocardial infraction, angina pectoris, and parenteral nutrition; thoymosin a1 for injection to treat hepatitis and impaired immunity, HBe antiogen-positive, decompensated liver cirrhosis, severe hepatitis, tumor relating hepatitis B, and chronic hepatitis C; and cefamandole nafate, ceftizoxime sodium, and isepamicin sulfate injection for the treatment of respiratory tract infections, genitourinary system infections, urinary tract infections, intra-abdominal infections, bone, joint infections, and septicemia. It also provides alanyl glutamine for injection that is indicated for catabolism and hypermetabolism; cefixime dispersible tablets to treat infections caused by streptococcus and pneumococcus, chronic bronchitis, acute bronchitis with bacterial infection, pneumonia, pyelonephritis, cystitis, gonococcal urethritis, and acute bacterial infection of the biliary tract system; and clostridium butyricum capsule for diarrhea and digestive system relevant illness. Further, the company offers marketing and promotion services. The company was founded in 2001 and is headquartered in Hangzhou, the People’s Republic of China.

Industry
Food & Drug Retailing
Sector
Consumer Non-Cyclicals
Employees
29
Market
Hong Kong

Compare 6108 to Peers and Sector

Metrics to compare
6108
Peers
Sector
Relationship
P/E Ratio
−2.4x−4.0x−0.5x
PEG Ratio
0.060.030.00
Price/Book
0.2x2.1x2.6x
Price / LTM Sales
0.8x1.5x3.3x
Upside (Analyst Target)
-−45.8%43.5%
Fair Value Upside
Unlock−10.0%6.8%Unlock

Earnings

Latest Release
Apr 24, 2025
EPS / Forecast
-0.16 / --
Revenue / Forecast
77.23M / --
EPS Revisions
a
a
Unlock
Last 90 days

6108 Income Statement

FAQ

What Stock Exchange Does New Ray Medicine Intl Trade On?

New Ray Medicine Intl is listed and trades on the Hong Kong Stock Exchange stock exchange.

What Is the Stock Symbol for New Ray Medicine Intl?

The stock symbol for New Ray Medicine Intl is "6108."

What Is the New Ray Medicine Intl Market Cap?

As of today, New Ray Medicine Intl market cap is 73.56M.

What Is New Ray Medicine Intl's Earnings Per Share (TTM)?

The New Ray Medicine Intl EPS (TTM) is -0.19.

From a Technical Analysis Perspective, Is 6108 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has New Ray Medicine Intl Stock Split?

New Ray Medicine Intl has split 3 times.

How Many Employees Does New Ray Medicine Intl Have?

New Ray Medicine Intl has 29 employees.

What is the current trading status of New Ray Medicine Intl (6108)?

As of 09 Aug 2025, New Ray Medicine Intl (6108) is trading at a price of 0.44, with a previous close of 0.42. The stock has fluctuated within a day range of 0.40 to 0.45, while its 52-week range spans from 0.32 to 0.84.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.